abstract |
The invention includes (a) four moieties capable of specifically binding to a costimulatory TNF receptor family member, (b) at least one moiety capable of specifically binding to a target cell antigen, and (c ) New bispecific antigen-binding molecules comprising Fc domains consisting of first and second subunits capable of stable association, methods for producing these molecules and methods for their use. [Selection figure] None |